Advertisement

Topics

Should US FDA Refuse Approval If Women Under-Represented In Clinical Trials?

20:12 EDT 17 May 2018 | SCRIP

Idea suggested during 'Great Debate,' but agency official says no adlibbing is allowed in the regulations.

      

Related Stories

 

Original Article: Should US FDA Refuse Approval If Women Under-Represented In Clinical Trials?

NEXT ARTICLE

More From BioPortfolio on "Should US FDA Refuse Approval If Women Under-Represented In Clinical Trials?"

Advertisement
Quick Search
Advertisement
Advertisement